Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N T Clausen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|June 21, 1976
[Serious metabolic anomalies. LVI. Factor V deficiency]J Gormsen, N T Clausen
Ugeskrift for Laeger|October 13, 1975
[Von Willebrand's disease]N T Clausen, J Gormsen
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Gamma'-dimer antibody and its specificity against fibrinogen, FR-a and carboxymethylated chains from fibrinogen and cross-linked fibrinN T Clausen, J Gormsen
Ugeskrift for Laeger|September 22, 1975
[Hemophilia A and B]J Gromsen, N T Clausen
Ugeskrift for Laeger|April 26, 1976
[Congenital defects in fibrin formation]N T Clausen, J Gormsen
Ugeskrift for Laeger|May 10, 1976
[Defects in the intrinsic pathway of the coagulation system]J Gormsen, N T Clausen
Ugeskrift for Laeger|August 6, 1973
[Immunological demonstration of fibrinogen-fibrin break-down products in serum and urine. Clinical significance]J Gormsen, N T Clausen
Ugeskrift for Laeger|June 7, 1976
[Inborn metabolism errors LV. Congenital "hypoprothrombinemia": Deficiency of II, VII or X]J Gormsen, N T Clausen
Ugeskrift for Laeger|April 15, 1974
[Low dosage of heparin. Theoretical and practical evaluation]J Gormsen, C Feddersen, N T Clausen
Scandinavian Journal of Haematology|July 1, 1985
A methodological evaluation of 14 controlled clinical trials in myelomatosisH S Birgens, O P Hansen, N T Clausen
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|June 21, 1976
[Serious metabolic anomalies. LVI. Factor V deficiency]J Gormsen, N T Clausen
Ugeskrift for Laeger|October 13, 1975
[Von Willebrand's disease]N T Clausen, J Gormsen
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Gamma'-dimer antibody and its specificity against fibrinogen, FR-a and carboxymethylated chains from fibrinogen and cross-linked fibrinN T Clausen, J Gormsen
Ugeskrift for Laeger|September 22, 1975
[Hemophilia A and B]J Gromsen, N T Clausen
Ugeskrift for Laeger|April 26, 1976
[Congenital defects in fibrin formation]N T Clausen, J Gormsen
Ugeskrift for Laeger|May 10, 1976
[Defects in the intrinsic pathway of the coagulation system]J Gormsen, N T Clausen
Ugeskrift for Laeger|August 6, 1973
[Immunological demonstration of fibrinogen-fibrin break-down products in serum and urine. Clinical significance]J Gormsen, N T Clausen
Ugeskrift for Laeger|June 7, 1976
[Inborn metabolism errors LV. Congenital "hypoprothrombinemia": Deficiency of II, VII or X]J Gormsen, N T Clausen
Ugeskrift for Laeger|April 15, 1974
[Low dosage of heparin. Theoretical and practical evaluation]J Gormsen, C Feddersen, N T Clausen
Scandinavian Journal of Haematology|July 1, 1985
A methodological evaluation of 14 controlled clinical trials in myelomatosisH S Birgens, O P Hansen, N T Clausen
Pageof 2